SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000795551-04-000011
Filing Date
2004-03-15
Accepted
2004-03-15 16:37:38
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 YEAR ENDED 2003 10-K ten-k.htm 10-K 698557
3 CONSENT FROM INDEPENENT AUDITORS e241.htm EX-23 1216
4 CERTIFICATION OF CEO ex31-1.htm EX-31 11279
5 CERTIFICATION OF CFO ex31-2.htm EX-31 11251
6 CERTIFICATION OF CEO UNDER SECTION 906 ex32-1.htm EX-32 2793
7 CERTIFICATION OF CFO UNDER SECTION 906 ex32-2.htm EX-32 2711
8 EXECUTIVE EMPLOYMENT AGREEMENT e1025.htm EX-10 107712
9 EXECUTIVE EMPLOYMENT AGREEMENT e1026a.htm EX-10 65659
10 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT e1027.htm EX-10 81252
11 FORM OF D&O IDEMNIFICATION AGREEMENT e1028.htm EX-10 29937
  Complete submission text file 0000795551-04-000011.txt   1015095
Mailing Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518
Business Address 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 7702710233
THERAGENICS CORP (Filer) CIK: 0000795551 (see all company filings)

IRS No.: 581528626 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14339 | Film No.: 04669991
SIC: 2834 Pharmaceutical Preparations